CATXNYSE American

Perspective Therapeutics, Inc.

Alert me on CATX

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Sep 9 Sale Lantheus Alpha Therapy, LLC Insider

1 week

−9.7%S&P −1.1%

1 month

−9.4%S&P +1.8%

3 months

Result in31 trading days

6 months

Result in94 trading days

Sep 9 Sale Lantheus Holdings, Inc. Insider

1 week

−9.7%S&P −1.1%

1 month

−9.4%S&P +1.8%

3 months

Result in31 trading days

6 months

Result in94 trading days

Sep 5 Sale Lantheus Alpha Therapy, LLC Insider

1 week

−12.5%S&P −1.1%

1 month

−21.2%S&P +1.7%

3 months

Result in30 trading days

6 months

Result in93 trading days

Sep 5 Sale Lantheus Holdings, Inc. Insider

1 week

−12.5%S&P −1.1%

1 month

−21.2%S&P +1.7%

3 months

Result in30 trading days

6 months

Result in93 trading days

Sep 5 Sale Lantheus Alpha Therapy, LLC Insider

1 week

−12.5%S&P −1.1%

1 month

−21.2%S&P +1.7%

3 months

Result in30 trading days

6 months

Result in93 trading days

Show all 9

Sep 4 Sale Lantheus Holdings, Inc. Insider

1 week

−6.7%S&P −1.2%

1 month

−24.6%S&P +1.4%

3 months

Result in29 trading days

6 months

Result in92 trading days

Sep 3 Sale Lantheus Holdings, Inc. Insider

1 week

−9.9%S&P −1.1%

1 month

−17.6%S&P +0.5%

3 months

Result in28 trading days

6 months

Result in91 trading days

Nov 17, 2025 Buy Hunt Jonathan Robert Insider

1 week

−1.8%S&P +0.5%

1 month

+17.2%S&P +0.9%

3 months

+155.7%S&P +3.1%

6 months

+70.6%S&P +12.0%

Nov 14, 2025 Buy Williamson Robert F III Insider

1 week

+0.5%S&P −1.9%

1 month

+36.5%S&P +1.0%

3 months

+141.8%S&P +2.4%

6 months

+74.5%S&P +9.8%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for CATX

33 held · newest 533 held · newest 2

Loading the filings.

See all 33 filings for CATX

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Sep 21, 2026 Schedule 13D, amended

Lantheus Holdings, Inc.: 7.7%, 8,739,011 shares

May 15, 2024 Schedule 13D, amended

Lantheus Holdings, Inc.: 10%, 11,440,513 shares

Aug 7, 2026 Schedule 13G, amended

Millennium Management LLC: 5.5%, 6,316,545 shares

Jun 30, 2026 Schedule 13G

STATE STREET CORPORATION: 5.3%, 6,051,771 shares

Jun 30, 2026 Schedule 13G

BlackRock, Inc.: 6.8%, 7,776,940 shares

Jul 13, 2026 Schedule 13G

Millennium Management LLC: 5.3%, 6,036,999 shares

Jun 23, 2026 Schedule 13G

Millennium Management LLC: 4.3%, 4,893,883 shares

Mar 31, 2026 Schedule 13G, amended

Morgan Stanley: 2.6%, 2,959,296 shares

Mar 31, 2026 Schedule 13G, amended

BlackRock, Inc.: 4.6%, 5,251,363 shares

Feb 20, 2026 Schedule 13G

Avidity Partners Management LP: 5.3%, 6,049,999 shares

Dec 31, 2025 Schedule 13G

Morgan Stanley: 6%, 4,461,893 shares

Feb 2, 2026 Schedule 13G

Commodore Capital LP: 9.9%, 11,939,753 shares

Feb 3, 2026 Schedule 13G

Chen Yu: 6.9%, 7,915,567 shares

Feb 4, 2026 Schedule 13G

Qatar Investment Authority: 6.2%, 7,073,308 shares

Nov 28, 2025 Schedule 13G, amended

FMR LLC: 0.4%, 312,164 shares

Oct 31, 2025 Schedule 13G, amended

FMR LLC: 8.2%, 6,063,330 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.